The observed concordance for the tumor-plasma NGS BRAF genotyping was also similar to the tissue-plasma concordance reported for the more sensitive method, ddPCR [14], and are in line with the results obtained for actionable mutations in other cancers [15]. This evidence concerns the gene BRAF and neoplasm.